Purpose Hepatocellular carcinoma (HCC) incidence rates have been increasing in the
United States for the past 35 years. Because HCC has a poor prognosis, quantitative …

Background & Aims Incidence rates for hepatocellular carcinoma (HCC) increased rapidly in
the United States since the 1990s, but have plateaued or started to decrease in other …

Purpose Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality
worldwide. Incidence rates are increasing in the United States. Monitoring incidence …

Background & Aims The incidence and mortality of hepatocellular carcinoma (HCC) have
been reported to be plateauing in the United States. The United States has large racial …

The incidence of hepatocellular carcinoma (HCC) has almost tripled since the early 1980s in
the United States, where it is the fastest rising cause of cancerrelated deaths. 1 According to …

Methods We assessed recent incidence rates and trends for hepatocellular carcinoma by
using newly available national data from cancer registries participating in the Centers for …

OBJECTIVES: The objectives were to describe Surveillance, Epidemiology and End Results
(SEER) hepatocellular carcinoma (HCC) incidence trends and the US liver cancer mortality …

The rise in incidence of hepatocellular carcinoma (HCC) in the United States has been well
documented. The purpose of this analysis was to examine temporal trends in HCC …

Background & Aims Liver cancer is highly fatal and the most rapidly increasing cancer in the
US, where chronic hepatitis C (HCV) infection is the leading etiology. HCV is particularly …

Background and Aims HCC is characterized by racial/ethnic disparities in rates. Recent USA
reports suggest that incidence has begun to decline, but it is not clear whether the declines …